ANOCCA AB
Anocca AB provides services like Biotechnology, Immunotherapeutics, Drug Discovery, Drug Development, Immunology.
ANOCCA AB
Social Links:
Industry:
Biotechnology
Founded:
2014-10-23
Address:
Södertälje, Vasternorrlands Lan, Sweden
Country:
Sweden
Website Url:
http://www.anocca.com
Total Employee:
11+
Status:
Active
Contact:
46841080757
Email Addresses:
[email protected]
Total Funding:
47 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx Euro Google Maps
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Current Employees Featured
Founder
Investors List
Ramsbury Invest AB
Ramsbury Invest AB investment in Series B - Anocca AB
Swedbank Robur’s Ny Teknik
Swedbank Robur’s Ny Teknik investment in Series B - Anocca AB
Robert Andreen
Robert Andreen investment in Series B - Anocca AB
Nidoco
Nidoco investment in Series B - Anocca AB
Harald Mix
Harald Mix investment in Series B - Anocca AB
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-08 | Anocca appoints Jacob Michlewicz as CFO |
Official Site Inspections
http://www.anocca.com
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Anocca AB"
About - Anocca
Anocca was founded in 2014 to build biotechnologies, processes and infrastructure needed to decode T-cell immunity, with the ambition to build new forms of T-cell immunotherapies. During the past decade we've invented, …See details»
Anocca - Crunchbase Company Profile & Funding
Anocca OS: A software platform that models T-cell biology, enabling data storage, organization, analysis, visualization, and automation for T-cell …See details»
Anocca - LinkedIn
Anocca is a fully integrated biopharmaceutical company that develops libraries of T-cell receptor-engineered T cell (TCR-T) therapies to redefine the treatment of solid tumours and other difficult ...See details»
Anocca 2025 Company Profile: Valuation, Funding
Anocca General Information Description. Developer of drugs and immunotherapies intended to unlock the therapeutic potential of T-cell …See details»
Anocca Company Profile - Office Locations, Competitors, Revenue …
Anocca is a biotechnology company that develops immunotherapies that leverage the immune system. It is focused on establishing a technology platform for analysis of T-cell biology to …See details»
Anocca - Overview, News & Similar companies | ZoomInfo.com
Anocca Announces Submission of Clinical Trial Application for Multi-asset Trial VIDAR-1 in Advanced Pancreatic Cancer · Application to the European Medicines Agency (EMA) covers …See details»
Anocca AB - VentureRadar
Anocca is a privately held Swedish biotechnology company founded in 2014 with the mission to establish a unique technology platform for analysis of T-cell biology to unlock the therapeutic …See details»
Anocca Company Information - Funding, Investors, and More
The company Anocca has raised a total of $26.56m in funding over 1 rounds. Key Insights: Debt Financing: $26.56m; 2025. Anocca Debt Financing (2022, $26M) $26.56m. Similar startup. …See details»
Anocca - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 18, 2025 Anocca. has raised a total funding of $120M over 3 rounds. Its first funding round was on Jul 22, 2021. What are the most recent funding rounds of Anocca? Its latest funding …See details»
Engineered Immunity by Anocca
Anocca is creating a pipeline of precision T-cell immunotherapies by combining its novel approach to T-cell biology, cutting-edge biotechnologies and integrated software. Our primary focus is to …See details»
Anocca raises SEK 400 million for large-scale development of …
May 31, 2023 Anocca AB. SÖDERTÄLJE, Sweden, May 31, 2023 (GLOBE NEWSWIRE) -- Anocca AB today announces that the company has successfully raised SEK 400 million …See details»
Anocca - Funding, Financials, Valuation & Investors - Crunchbase
Anocca is a drug and immunotherapy developer aiming to uncover the therapeutic potential of T-cell immunity. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
Welcome to our career page - Anocca
Anocca is on a mission to transform treating cancer & other serious diseases. Anocca is a leading precision immunotherapy company, building libraries of treatments that will transform the …See details»
Anocca AB - VentureRadar
" Anocca is a privately held Swedish biotechnology company founded in 2014 with the mission to establish a unique technology platform for analysis of T-cell biology to unlock the therapeutic …See details»
Our Science - Anocca
We've built novel technologies, powerful analytical platforms and an integrated software ecosystem to systematically decode T-cell biology. T-cells protect us from cancer and …See details»
Anocca AB (Anocca AB) - 药物管线_专利_临床试验_投融营收_最新 …
了解Anocca AB (Anocca AB)公司的药物管线，治疗领域，技术平台，以及它的12篇新闻，疾病领域:肿瘤，技术平台:TCR细胞疗法，药物:NY-ESO-1 (Anocca)，TCR-T cell therapies …See details»
Anocca Announces Authorisation of Clinical Trial Application to …
SÖDERTÄLJE, SWEDEN, 17 March 2025 – Anocca AB, a leading T-cell immunotherapy company, announces the authorisation of its Clinical Trial Application (CTA) from the …See details»
Anocca - Contacts, Employees, Board Members, Advisors
Anocca is a drug and immunotherapy developer aiming to uncover the therapeutic potential of T-cell immunity. New. ... Experience the new Crunchbase, powered by AI . Organization. Anocca …See details»
News - Anocca
Anocca Announces Submission of Clinical Trial Application for Multi-asset Trial VIDAR-1 in Advanced Pancreatic Cancer. In Brief-- Application to the European Medicines Agency (EMA) …See details»
Anocca Announces Submission of Clinical Trial Application for …
SÖDERTÄLJE, SWEDEN, 26 November 2024 – Anocca AB, a leading T-cell receptor-engineered T-cell (TCR-T) cellular therapeutics company, announces the submission of its first Clinical …See details»